FindTrial
Sign In

Study on the benefit of the use of protocols in the care of chest pain in emergency physicians of the Cardiology Institute of Santa Catarina

Compliance assessment to the Recommendations of the Corporate Guidelines through a Protocol Approach to Acute Coronary Syndrome by residents in the Emergency Room of Cardiology Institute of Santa Catarina: a Cluster Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4mxksj
Enrollment
Unknown
Registered
2011-12-14
Start date
2011-05-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence to the guidelines of the residents in meeting the corporate chest pain and acute coronary syndrome in the emergency room.

Interventions

- Protocol Group (residents randomized to receive protocol guidance of conduct in the care of patients with chest pain in emergency, according to guidelines of the Brazilian Society of Cardiology)
- Control Group (group of residents randomized to not receive the protocol)
behavioural
N04.761.337

Sponsors

Instituto de Cardiologia de Santa Catarina
Lead Sponsor
Instituto de Cardiologia de Santa Catarina
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All eight residents of Instituto de Cardiologia de Santa Catarina will be included in the study.

Exclusion criteria

Exclusion criteria: Residents who do not agree to sign the term of consent form (free and clear).

Design outcomes

Primary

MeasureTime frame
Combined endpoint (sum of points) will be awarded 1 point for each of the channels with Class I and IIa according to guidelines of the Brazilian Society of Cardiology: History and physical examination described; Classification of pain; Electrocardiogram within 10 minutes; Electrocardiogram repeated in 6 hours if no diagnosis; TIMI risk stratification; Cardiac monitoring; Determination of CK-MB and troponin; Primary angioplasty is infarction with ST elevation to <12 h; Oxigen for intermediate and high risk; Use of aspirin 100 to 200mg; Use of Clopidogrel 300 mg; Use of Isordil or nitroglycerin; Use of morphine if pain; Use of beta-blocker is intermediate or high risk; Use of enoxaparin; Use of statins; Use of ACE inhibitors in the first 24h.—

Secondary

MeasureTime frame
Average hospital stay of two groups of patients conducted by the two randomized groups of physicians; ;Comparison between the rates of in-hospital mortality of patients admitted with clinical suspicion of ACS; ;Comparison each of the individual approaches used for the sum in the combined endpoint (primary).—

Countries

Brazil

Contacts

Public ContactMasterson;Daniel de Farias;Moreira

Instituto de Cardiologia de Santa Catarina;Instituto de Cardiologia de Santa Catarina

masterson@yahoo.com.br;danielmedeirosmoreira@hotmail.com91497720;84175590

Outcome results

None listed

Source: REBEC (via WHO ICTRP)